305例SLE flare患者用药依从性前瞻性国际研究:药物浓度与自评问卷评估
该国际研究纳入305例系统性红斑狼疮(SLE) flare患者,用羟氯喹(HCQ)血药浓度(HCQ<200 ng/ml或去乙基氯喹不可测)和自评问卷(MASRI<80%或MMAS-8<6)评估不依从。药物浓度定义18.4%患者为严重不依从,问卷分类39.9%为不依从,两法相关性中等,提示治疗药物监测在此情境有用。
要点
- 药物浓度显示18.4%的SLE flare患者严重不依从。
- 自评问卷分类39.9%的患者为不依从。
- 年轻、未用激素、高BMI和失业与药物浓度定义的不依从相关。
核心结论
- 药物浓度与自评问卷可能测量两种不同模式的不依从,问卷多捕捉偶尔漏服,药物浓度识别严重不依从。
- 医生常漏判不依从且患者低报,提示治疗药物监测在此情境有用。
研究设计与样本
- 前瞻性国际研究,纳入305例SLE flare患者,用药物浓度和自评问卷评估不依从。
主要发现
- 药物浓度定义18.4%患者为严重不依从。
- 问卷分类39.9%患者为不依从。
- 多变量分析中,年轻、未用激素、较高BMI和失业与药物浓度定义的不依从相关。
- 问卷、药物浓度和医生评估之间的相关性为中等。
关键数值与推荐
- 药物浓度不依从标准:HCQ<200 ng/ml或去乙基氯喹不可测。
- 问卷不依从标准:MASRI<80%或MMAS-8<6。
临床怎么用
- 对SLE flare患者可考虑用HCQ血药浓度识别严重不依从。
- 自评问卷可辅助捕捉偶尔漏服,但与药物浓度相关性中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonadherence to treatment is a major cause of lupus flares. Hydroxychloroquine (HCQ), a major medication in systemic lupus erythematosus, has a long half-life and can be quantified by high-performance liquid chromatography. This international study evaluated nonadherence in 305 lupus patients with flares using drug levels (HCQ <200 ng/ml or undetectable desethylchloroquine), and self-administered questionnaires (MASRI <80% or MMAS-8 <6). Drug levels defined 18.4% of the patients as severely nonadherent. In multivariate analyses, younger age, nonuse of steroids, higher body mass index, and unemployment were associated with nonadherence by drug level. Questionnaires classified 39.9% of patients as nonadherent. Correlations between adherence measured by questionnaires, drug level, and physician assessment were moderate. Both methods probably measured two different patterns of nonadherence: self-administered questionnaires mostly captured relatively infrequently missed tablets, while drug levels identified severe nonadherence (i.e., interruption or erratic tablet intake). The frequency with which physicians miss nonadherence, together with underreporting by patients, suggests that therapeutic drug monitoring is useful in this setting. (Trial registration: ClinicalTrials.gov: NCT01509989.).
引用
- Costedoat-Chalumeau N, Houssiau F, Izmirly P, et al. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. Clin Pharmacol Ther. 2017. PMID: 28925027. doi:10.1002/cpt.885
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。